Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jose B. Vazquez‐Tanus"'
Autor:
Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Background Although safety and tolerability of vericiguat were established in the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) trial in patients with heart failure with reduced ejection fraction, so
Externí odkaz:
https://doaj.org/article/746573cb9e5446779c083cce06f77a82
Autor:
Mahesh J. Patel, Kevin J. Anstrom, Jose B. Vazquez‐Tanus, Carolyn S.P. Lam, Lothar Roessig, Paul W. Armstrong, Yuri Lopatin, Christopher M. O'Connor, Adrian F. Hernandez, Hillary Mulder, Justin A. Ezekowitz, Burkert Pieske, David C. W. Siu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Background Although safety and tolerability of vericiguat were established in the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) trial in patients with heart failure with reduced ejection fraction, so
Autor:
Burkert, Pieske, Mahesh J, Patel, Cynthia M, Westerhout, Kevin J, Anstrom, Javed, Butler, Justin, Ezekowitz, Adrian F, Hernandez, Joerg, Koglin, Carolyn S P, Lam, Piotr, Ponikowski, Lothar, Roessig, Adriaan A, Voors, Christopher M, O'Connor, Paul W, Armstrong, Jian, Zhang
Publikováno v:
Pieske, B, Patel, M J, Westerhout, C M, Anstrom, K J, Butler, J, Ezekowitz, J, Hernandez, A F, Koglin, J, Lam, C S P, Ponikowski, P, Roessig, L, Voors, A A, O'Connor, C M, Armstrong, P W & VICTORIA Study Group 2019, ' Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial ', European Journal of Heart Failure, vol. 21, no. 12, pp. 1596-1604 . https://doi.org/10.1002/ejhf.1664
European Journal of Heart Failure
European Journal of Heart Failure, 2019, 21 (12), pp.1596-1604. ⟨10.1002/ejhf.1664⟩
European Journal of Heart Failure, 21(12), 1596-1604. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, 2019, 21 (12), pp.1596-1604. ⟨10.1002/ejhf.1664⟩
European Journal of Heart Failure, 21(12), 1596-1604. Wiley
International audience; Aim: Describe the distinguishing features of heart failure (HF) patients with reduced ejection fraction (HFrEF) in the VICTORIA (Vericiguat Global Study in Patients with Heart Failure with Reduced Ejection Fraction) trial.Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c0559faf46b4ff186b6cd3dfba3f3e
https://pure.au.dk/portal/da/publications/baseline-features-of-the-victoria-vericiguat-global-study-in-subjects-with-heart-failure-with-reduced-ejection-fraction-trial(abef0460-5e68-4f8f-9aab-7efe513d1837).html
https://pure.au.dk/portal/da/publications/baseline-features-of-the-victoria-vericiguat-global-study-in-subjects-with-heart-failure-with-reduced-ejection-fraction-trial(abef0460-5e68-4f8f-9aab-7efe513d1837).html